MarketersMEDIA / Newsroom / CD Bioparticles Releases Chitosans for Research Use

CD Bioparticles Releases Chitosans for Research Use

Share This Press Release

CD Bioparticles launches a series of chitosans for global research communities to support drug delivery studies.

— As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles launches a series of chitosans for global research communities to support drug delivery studies. These new chitosans and derivatives are with various water solubility, and scientists now are accessible to products like CInd™ analogous hyaluronic acid chitosan, CInd™ carboxymethyl chitosan, CInd™ chitosan azelate and glycol chitin.

One new product in this new release is the CInd™ Chitosan Azelate, which is water soluble, and the solution is neutral, clear and stable. Chitosan Azelate can be used in speckle-removing skin care cosmetic, which has the role of Azelate of bacteriostasis, elimination of melanin and acne; it also has the function of chitosan of biocompatibility and filming, which can inhibit the bacteria, mold, and melanin synthesis enzyme activity. Compared to the other speckle-removing skin care cosmetic, the advantage of this product is that it is effective with higher levels of azelaic acid, which can be achieved 4% of the total weight; it also has other advantages such as speckle-removing, anti acne, whitening, moisturizing and antiwrinkle. It is used as cosmetics or cosmetic raw materials, without side effects.

Another example is CInd™ Chitosan Lactate, which is off-white or yellowish powder. Chitosan lactate with a better biocompatibility has excellent functions of antibacterial activity, moisture retention, preventing disease, keeping healthy and other special purposes. It is widely used in the fields like dressing, hygienic materials, biochemistry, health foods, functional food, food additives, and intermediates. Chitosan lactate is made from natural raw materials, without touching the other chemical raw materials in the production process, therefore it is more natural and safe.

CD Bioparticles offers biopolymers & synthetic polymers for assisting customers' drug delivery research programs, and this new series of chitosans, together with its customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos, and advanced technical platforms can help researchers to solve different drug delivery challenges during the study. "Our chitosan products are organized by functional groups, namely N/A, biotin, hydroxyl, and thiol. You can easily find each of our chitosan polymers and inquiry about these new products." said Dr. Robin J. Watts, the product portfolio manager of CD Bioparticles.

For more detailed information on chitosans or biopolymers & synthetic polymers, please contact CD Bioparticles or visit its website directly at https://www.cd-bioparticles.net/.

About CD Bioparticles

CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems. It specializes in a range of formulation and drug delivery technologies, from conventional liposomes, PEGylated liposomes for drug delivery to polymer microspheres and nanoparticles for enhanced drug delivery. It provides contract services of drug delivery formulation developments for basic research, formulation feasibility studies, process development and scale-up, formulation characterization, analytical and nonclinical services.

Contact Info:
Name: Richard J. Gray
Email: Send Email
Organization: CD Bioparticles
Website: https://www.cd-bioparticles.net/

Source URL: https://marketersmedia.com/cd-bioparticles-releases-chitosans-for-research-use/88990888

Source: MarketersMedia

Release ID: 88990888

Subscribe and Receive exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2021 MarketersMEDIA – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).